Feasibility of telemedicine in detecting diabetic retinopathy and age-related macular degeneration

Seminars in Ophthalmology

Volumn 30, Issue 2, 2015, Pages 81-95

  Vaziri, Kamyar ^a   Moshfeghi, Darius M ^b   Moshfeghi, Andrew A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetic retinopathy; Macular degeneration; Telemedicine; Teleophthalmology; Teleretina

Indexed keywords

AGE RELATED MACULAR DEGENERATION; DIABETIC RETINOPATHY; DIAGNOSTIC ACCURACY; DIGITAL IMAGING; ECONOMIC ASPECT; FEASIBILITY STUDY; HUMAN; IMAGE QUALITY; PATIENT SATISFACTION; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; REVIEW; TELEMEDICINE; VALIDITY; MACULAR DEGENERATION; PROCEDURES; TELEPATHOLOGY;

DIABETIC RETINOPATHY; FEASIBILITY STUDIES; HUMANS; MACULAR DEGENERATION; TELEPATHOLOGY;

EID: 84924036429     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.3109/08820538.2013.825727     Document Type: Review

References (68)

1. Ritcher GM, Williams SL, Starren J, et al. Telemedicine for retinopathy of prematurity diagnosis: Evaluation and challenges. Surv Ophthalmol 2009;54(6):671-685.
2. Congdon N, O'Colmain B, Klaver CC, et al., Eye Diseases Prevelance Research Group. Causes and prevalence of visual impairment among adults in the U.S. Arch Ophthal 2004;122(4):477-485.
3. Zhang X, Saadine J, Chou CF, et al. Prevelence of diabetic retinopathy in the U.S., 2005-2008. JAMA 2010; 204(6):649-656.
4. Pizzarello LD. The dimension of the problem of eye disease among the elderly. Ophthalmology 1987;94:1191-1195.
5. Kempen JH, O'Colmain BJ, Leske MC, et al., The Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 2004;122(4):552-563.
6. Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 2007;14(4):179-183.
7. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317(7160):703-713.
8. Ho T, Smiddy WE, Flynn Jr HW. Vitrectomy in the management of diabetic eye disease. Surv Ophthalmol 1992;37(3):190-202.
9. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study report 2. Arch Ophthalmol 1985;103(11):1644-1652.
10. Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathycomplicated by vitreous hemorrhage. Retina 2006;26(3):275-278.
11. Avery RF, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006; 113(10):1695.el-15.
12. American Academy of Ophthalmology Retina Panel. Preferred Practice Pattern Guidelines: Diabetic Retinopathy; San Francisco, CA: American Academy of Ophthalmology, 2008. Available at: http://one.aao.org/CE/PracticeGuidelines/PPP.aspx. [last accessed 5 October 2012].
13. Shoenfeld ER, Greene JM, Wu SY, Leske MC. Patterns of adherence of diabetes vision care guidelines: Baseline findings from the Diabetic Retinopathy Awareness Program. Ophthalmology. 2001;108(3):563-571.
14. Klein R, Klien BE. Screening for diabetic retinopathy, revisited. Am J Ophthalmol 2002;134(2):261-263.
15. Hartness ME, Key IJ, Loyacano NM, et al. Perceived barriers to diabetic eye care. Arch Ophthalmol 2005; 123(3):387-391.
16. Mabereley DA, Koushik A, Cruess AF. Factors associated with missed eye examinations in a cohort with diabetes. Can J Public Health 2002;93(3):229-232.
17. Mukamel DB, Brensick GH, Wang Q, Dickey CF. Barriers to compliance with screening guidelines for diabetic retinop-athy. Ophthalmic Epidemiol 1999;6(1):61-72.
18. Cavallerano J, Lawrence MG, Zimmer-Galler I, et al. Telehealth practice recommendations for diabetic retinop-athy. Telemed J E Health 2004;10(4):469-482.
19. Williams GA, Scott I, Haller JA, et al. Single-field fundus photography for diabetic retinopathy screening: A report by the American Academy of Ophthalmology. Ophthalmology 2004;111(5):1055-1062.
20. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs: An extension of the modified Airlie House classification. ETDRS report no. 10. Ophthalmology 1991; 98(5 Suppl): 786-806.
21. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report no. 12. Ophthalmology 1991; 98(5 Suppl): 823-833.
22. Fransen SR, Leonard-Martin TC, Feuer WJ, Hildebrand PL. Clinical evaluation of patients with diabetic retinopathy: Accuracy of the Inoveon diabetic retinopathy-3DT system. Ophthalmology 2002;109(3):595-601.
23. Lin DY, Blumenkranz MS, Brothers RJ, Grosvenor DM. The sensitivity and specificity of single-field non-mydriatic monochromatic digital fundus photography with remote image interpretation of diabetic retinopathy screening: A comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol 2002; 134(2):204-213.
24. Bursell SE, Cavallerano JD, Cavallerano AA, et al. Stereo non-mydriatic digital-video color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy. Ophthalmology 2001;109(3):L572-585.
25. Rudinksy CJ, Tennant MT, Weis E, et al. Web-based grading of compressed stereoscopic digital photography versus standard slide film photography for the diagnosis of diabetic retinopathy. Ophthalmology 2007; 114(9):1748-1754.
26. The Diabetic Retinopathy Study Research group. A modification of the Airlie House classification of diabetic retinopathy. Report 7. Invest Ophthalmol Vis Sci 1981;21: 210-226.
27. Silva PS, Cavallerano JD, Sun JK, et al. Non-mydriatic ultra-widefield retinal imaging compared to dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy. Am J Ophthalmol 2012;154(3):549-559.
28. Li HK, Esquivel A, Hubbard LD, et al. Mosaics versus Early Treatment Diabetic Retinopathy Study: Seven standard fields for evaluation of diabetic retinopathy severity. Retina 2011;31(8):1553-1563.
29. Schiffman RM, Jacobsen G, Nussbaum JJ, et al. Comparison of a digital retinal imaging system and seven-field stereo color fundus photography to detect diabetic retinopathy in the primary care environment. Ophthalmic Surg Lasers Imaging 2005;36(1):46-56.
30. Vujosevic S, Benetti E, Massignan F, et al. Screening for Diabetic Retinopathy: 1 and 3 nonmydriatic 45-degree digital fundus photographs vs 7 standard Early Treatment Diabetic Retinopathy Study fields. Am J Ophthalmo. 2009; 148(1):111-118.
31. Li HK, Horton M, Bursell SE, et al. Telehealth practice recommendations for diabetic retinopathy, second edition. Telemed J E Health 2011;17(10):814-837.
32. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
33. Kernt M, Hadi I, Pinter F, et al. Assessment of diabetic retinopathy using non-mydriatic ultra-widefield scanning laser ophthalmoscopy (Optomap) compared with ETDRS 7-field stereo photography. Diabetes Care 2012;35(12): 2459-2463.
34. Pascolini D, Mariotti SP, Pokharel GP, et al. 2002 global update of available data on visual impairment: A compilation of population-based prevalence studies. Ophthalmic Epidemiol 2004;11(2):67-115.
35. Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122(4):564-572.
36. Klein R, Chou CF, Klein BE, et al. Prevalence of Age-Related Macular Degeneration. San Francisco: American Academy of Ophthalmology, 2008.
37. Klein R, Chou CF, Klein BE, et al. Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol 2011;129(1):75-79.
38. Klein R, Klein BE, Knudtson MD, et al. Fifteen-year cumulative incidence of age-related macular degeneration: The Beaver Dam Eye Study. Ophthalmology 2007;114(2): 253-262.
39. The Age-Related Eye Disease Study Research Group. A randomized placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 2001;199(10):1417-1436.
40. Lim SL, Mitchell P, Seddon JM, et al. Age-related macular degeneration. Lancet 2012;379(9827):1728-1738.
41. American Academy of Ophthalmology. Preferred Practice Pattern Guidelines: Comprehensive Adult Medical Eye Evaluation; San Francisco, CA: American Academy of Ophthalmology, 2010. Available at: http://one.aao.org/CE/PracticeGuidelines/PPP-Content.aspx?cid=64e9df91-dd10-4317-8142-6a87eee7f517. [last accessed 5 October 2012].
42. Vingerling JR, Diemlemans I, Hofman A, et al. The prevalence of age-related macular degeneration in the Rotterdam Study. Ophthalmology 1992;99:933-943.
43. Augood CA, Vingerling JR, de Jong PT, et al. Prevalence of age-related maculopathy in the older Europeans: The European Eye Study (EUREYE). Arch Ophthalmol 2006; 124(4):529-535.
44. Gibson DM. Diabetic retinopathy and age-related macular degeneration in the U.S. Am J Prev Med 2012;43(1):48-54.
45. Kelly SP, Wallwork I, Haider D, Qureshi K. Teleophthalmology with optical coherence tomography imaging in community optometry: Evaluation of a quality improvement for macular patients. Clin Ophthalmol 2011;5: 1673-1678.
46. Lim J, Labree L, Nichold T, Cardenas I. Comparison of non-mydriatic digitized video fundus images with standard 35-mm slides to screen for and identify specific lesions of age-related macular degeneration. Retina 2002;22(1):59-64.
47. Pirbhai A, Sheidow T, Hooper P. Prospective evaluation of digital non-stereo color fundus photography as a screening tool in age-related macular degeneration. Am J Ophthalmol 2005;139(3):455-461.
48. Jain S, Hamada S, Membrey WL, Chong V. Screening for age-related macular degeneration using non-stereo digital fundus photographs. Eye 2006;20(4):471-475.
49. Zimmer-Galler IE, Zeimer R. Feasibility of screening for high-risk age-related macular degeneration with an internet-based automated fundus camera. Ophthalmic Surg Lasers Imaging 2005;36(3):228-236.
50. Le Tien V, Streho M, d'Athis P, et al. Interobserver and intraobserver reliability of detecting age-related macular degeneration using a non-mydriatic digital camera. Am J Ophthalmol 2008;146(4):520-526.
51. Conlin PR, Fisch BM, Orcutt JC, et al. Framework for a national teleretinal imaging program to screen for diabetic retinopathy in Veterans Health Administration patients. J Rehabil Res Dev 2006;43(6):741-748.
52. Kawasaki S, Ito S, Mori Y, et al. Use of telemedicine in periodic screening of diabetic retinopathy. Teleme J E Health 2003;9(3):235-239.
53. Lee MS, Shin DS, Berger JW. Grading, image analysis, and stereopsis of digitally compressed fundus images. Retina 2000;20:275-281.
54. Boucher MC, Nguyen QT, Angioi K. Mass community screening for diabetic retinopathy using a nonmydriatic camera with telemedicine. Can J Ophthalmol 2005; 40(6):734-742.
55. Paul PG, Raman R, Rani PK, et al. Patient satisfaction levels during teleophthalmology consultation in rural South India. Telemed J E Health 2006;12(5):571-578.
56. Maberley D, Walker H, Koushik A, Cruess A. Screening for diabetic retinopathy in James Bay, Ontario: A cost-effectiveness analysis. CMAJ 2003;168(2):160-164.
57. Aoki N, Dunn K, Fukui T, et al. Cost-effectiveness analysis of telemedicine to evaluate diabetic retinopathy in a prison population. Diabetes Care 2004;27(5):1095-1101.
58. Whited JD, Datta SK, Aiello LM, et al. A modeled economic analysis of a digital teleophthalmology system as used by three federal healthcare agencies for detecting proliferative diabetic retinopathy. Telemedicine Journal & E-Health 2005; 11(6):641-651.
59. Rein DB, Wittenborn JS, Zhang X, et al. The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy. Health Serv Res 2011;46(5):1534-1561.
60. Gomez-Ulla F, Alonso F, Aibar B, et al. A comparative cost analysis of digital fundus imaging and direct fundus examination for assessment of diabetic retinopathy. Telemedicine & E-Health 2008;14(9):912-918.
61. Massin P, Aubert JP, Eschwege E, et al. Evaluation of a screening program for diabetic retinopathy in a primary care setting Dodia (Dépistage ophtalmolo-gique du diabète) study. Diabetes Metab 2005;31: 153-162.
62. van Leeuwen R, Chakravarthy U, Vingerling JR, et al. Grading of age-related maculopathy for epidemiological studies: Is digital imaging as good as 35-mm film? Ophthalmology 2003;110(8):1540-1544.
63. Kirkpatrick JN, Manivannan A, Gupta AK, et al. Fundus imaging in patients with cataract: Role for a variable wavelength scanning laser ophthalmoscope. Br J Ophthalmol 1995;79(10):892-899.
64. Zeimer R, Zou S, Meeder T, et al. A fundus camera dedicated to the screening of diabetic retinopathy in the primary-care physician's office. Invest Ophthalmol Vis Sci 2002;43(5):1581-1587.
65. Abramoff MD, Suttorp-Schulten MSA. Web-based screening for diabetic retinopathy in a primary care population: The EyeCheck project. Telemedicine Journal & e-Health 2005; 11(6):668-674.
66. Romero-Aroca, P, Sagarra-Alamo R, Basora-Gallisa J, et al. Prospective comparison of two methods of screening for diabetic retinopathy by nonmydriatic fundus camera. Clin Ophthalmol 2010;4:1481-1488.
67. Taylor CR, Merin LM, Salunga AM, et al. Improving diabetic retinopathy screening ratios using telemedicine-based digital retinal imaging technology. Diabetes Care 2007;30(3):574-578.
68. Hubbard LD, Sun W, Cleary PA, et al. Comparison of digital and film grading of diabetic retinopathy severity in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Arch Ophthalmol 2011;129(6):718-726.